Events

November
29th
December
4th
UPCOMING EVENT

RSNA Annual Meeting

Visit our partners Sectra, Change Healthcare, and GE Healthcare for a demo of Veye Chest, the lung nodule management solution trusted in clinical practice and lung cancer screening sites across Europe. 

More information
November
19th
PAST EVENT

BSTI/BIR Annual Virtual Meeting

12:30 – 17:35 GMT: The opportunity to learn more about lung health checks and difficult patterns of lung diseases, among other topics.

More information
November
10th
PAST EVENT

Personalised Medicine: Personalised Services for Cancer Care

13:00 GMT: “The potential of AI to improve early detection and treatment strategies for lung cancer” with Dr. Neal Navani and Jeroen van Duffelen

SPEAKERS

Dr. Neal Navani

Dr. Neal Navani
Consultant Respiratory Physician at University College London Hospital and Associate Professor at University College London

Jereon van Duffelen

Jereon van Duffelen
Co-founder and COO, Aidence

November
5th
PAST EVENT

BIR Annual Congress

15:35 GMT: “The role of AI in developing the targeted lung health check (TLHC) programme” with Dr. James Shambrook

More information

SPEAKERS

Dr. James Shambrook

Dr. James Shambrook
Consultant Cardiothoracic Radiologist, University Hospital Southampton NHS Foundation Trust

October
19th
PAST EVENT

BSTI Lung Cancer Screening Training

Join us for a training on lung nodules, presented by Dr. Arjun Nair and Dr. Graham Robinson, funded by the NHS and sponsored by the British Society of Thoracic Imaging.

SPEAKERS

Dr. Arjun Nair

Dr. Arjun Nair
Consultant Radiologist, University College London Hospitals NHS Foundation Trust

Dr. Graham Robinson

Dr. Graham Robinson
President of the British Society Thoracic Imaging (BSTI), Consultant Radiologist

September
11th
PAST EVENT

BIR Lung Cancer Imaging: Update for the not-so-new-normal

15:50 BST: “Assuring quality in the lung cancer pathway: A data-driven approach” with Dr. Lizzie Barclay and Jeroen van Duffelen

SPEAKERS

Jeroen van Duffelen

Jeroen van Duffelen
Co-founder and COO, Aidence

Lizzie Barclay

Lizzie Barclay
Medical Director, Aidence

September
2nd
September
4th
PAST EVENT

Dutch Radiology Days

Join Aidence at the combined radiology sessions organised by the Radiology days and the Sandwich course committees. Featuring expert speakers, cross-curricular talks, and industry insights.

VIRTUAL SESSIONSECR Virtual Sessions

Watch on-demand our webinars broadcasted during the ECR2020.

What AI will bring to radiology in the next 5 years

SPEAKERS

Mark-Jan Harte

Mark-Jan Harte
CEO and Co-founder

Jeroen van Duffelen

Jeroen van Duffelen
COO and Co-founder

Get started with AI in your practice: a practical guide

SPEAKERS

Mark-Jan Harte

Mark-Jan Harte
CEO and Co-founder

Jeroen van Duffelen

Jeroen van Duffelen
COO and Co-founder

Why AI is the key to effective and sustainable lung cancer screening

SPEAKERS

Dr. Lizzie Barclay

Dr. Lizzie Barclay
Medical Director

Jeroen van Duffelen

Jeroen van Duffelen
COO and Co-founder

Latest
news

Aidence and Inobe partner up to bring AI to lung cancer care in Poland

November 4, 2020

Aidence and Inobe, leading MedTech distributor based in Warsaw, announce a partnership to pioneer artificial ... Continue reading...

Aidence is one of the first to obtain CE mark for AI-based solution under MDR 2017/745

October 28, 2020

Aidence is one of the first in its field to have been granted the CE ... Continue reading...

University Hospital Southampton resumes lung health checks using Veye Chest

October 8, 2020

University Hospital Southampton NHS Foundation Trust is using artificial intelligence (AI) to detect lung cancer ... Continue reading...

Aidence receives AI in Health and Care Award to help the NHS improve lung cancer prognosis

September 8, 2020

Aidence has won an Artificial Intelligence (AI) in Health and Care Award to support the UK’s National ... Continue reading...

Aidence becomes British Institute of Radiology corporate member

July 27, 2020

Aidence has become a corporate member of the British Institute of Radiology (BIR). Aidence’s mission is ... Continue reading...

Liverpool Heart and Chest Hospital partners with Aidence to use AI in clinical practice and lung cancer screening

July 23, 2020

Liverpool Heart and Chest Hospital NHS Foundation Trust (LHCH) has partnered with Amsterdam-based medtech company ... Continue reading...

Affidea partners with Aidence in lung cancer screening and diagnosis

December 4, 2019

Affidea and Aidence announce a strategic partnership to streamline and improve the clinical performance of ... Continue reading...

Aidence raises €10 million Series A to revolutionise the medical imaging industry

February 15, 2019

As Aidence, we are proud to announce we have completed a €10 million Series A ... Continue reading...

Four abstracts featuring Veye Chest will be presented at the European Congress of Radiology (ECR)

February 5, 2019

We are very proud to announce that the results from a recently completed clinical study ... Continue reading...

Aidence sponsors the first Medical Imaging Deep Learning (MIDL) conference

June 25, 2018

The first Medical Imaging Deep Learning (MIDL) conference will take place in our home town ... Continue reading...

Aidence extends its advisory board with leading clinical and deep learning experts

May 16, 2018

The Aidence team is proud to announce Dr. Arjun Nair and Dr. Diederik Kingma will ... Continue reading...

Aidence receives the SBRI Healthcare Development Award to help bring new technology to the NHS

February 23, 2018

Aidence, a startup developing medical imaging diagnostic software based on deep learning, announces that it ... Continue reading...

Aidence receives CE mark for AI-based Veye Chest

December 12, 2017

Aidence, a startup developing medical imaging diagnostic software based on deep learning, announces that it ... Continue reading...

Book a demo


    * Required fields.
    For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.